Ensoma names new CEO

By The Science Advisory Board staff writers

October 11, 2021 -- Ensoma has named Emile Nuwaysir, PhD, as its new president and CEO.

Nuwaysir is currently chair of the Alliance for Regenerative Medicine and vice chair of Invenra, an antibody platform company he co-founded in 2011. He previously served as CEO at BlueRock Therapeutics, a Bayer Pharmaceuticals subsidiary, and will continue to chair that company's board. Before his position at BlueRock, Nuwaysir was president and CEO of Cellular Dynamics International and a member of senior management at NimbleGen Systems.


Copyright © 2021 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.